Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Adebrelimab Plus Apatinib as the First-line Treatment for Hepatocellular Carcinoma in Barcelona Clinic Liver Cancer Stage C: An Open-label, Single-arm, Phase II Study

NCT06482008 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT06482008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06482008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Adebrelimab Plus Apatinib as the First-line Treatment for Hepatocellular Carcinoma in Barcelona Clinic Liver Cancer Stage C: An Open-label, Single-arm, Phase II Study
Lead sponsor
Sun Yat-sen University
Phase
Phase 2
Overall status
Unknown status
Start date
June 19, 2024
Completion date
February 1, 2026
Enrollment
33 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma